Annual CFI
$800.00 K
-$16.76 M-95.44%
December 31, 2023
Summary
- As of February 6, 2025, GLMD annual cash flow from investing activities is $800.00 thousand, with the most recent change of -$16.76 million (-95.44%) on December 31, 2023.
- During the last 3 years, GLMD annual CFI has fallen by -$15.74 million (-95.16%).
- GLMD annual CFI is now -95.44% below its all-time high of $17.56 million, reached on December 31, 2022.
Performance
GLMD Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$614.00 K
-$778.00 K-55.89%
September 30, 2024
Summary
- As of February 6, 2025, GLMD quarterly cash flow from investing activities is $614.00 thousand, with the most recent change of -$778.00 thousand (-55.89%) on September 30, 2024.
- Over the past year, GLMD quarterly CFI has increased by +$4.15 million (+117.37%).
- GLMD quarterly CFI is now -97.17% below its all-time high of $21.68 million, reached on September 30, 2018.
Performance
GLMD Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$4.72 M
+$4.15 M+730.46%
September 30, 2024
Summary
- As of February 6, 2025, GLMD TTM cash flow from investing activities is $4.72 million, with the most recent change of +$4.15 million (+730.46%) on September 30, 2024.
- Over the past year, GLMD TTM CFI has increased by +$4.22 million (+843.40%).
- GLMD TTM CFI is now -84.54% below its all-time high of $30.51 million, reached on June 30, 2019.
Performance
GLMD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GLMD Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -95.4% | +117.4% | +843.4% |
| 3 y3 years | -95.2% | +117.4% | +843.4% |
| 5 y5 years | +101.3% | +117.4% | +843.4% |
GLMD Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -95.4% | at low | -90.4% | +117.4% | -78.5% | +4063.9% |
| 5 y | 5-year | -95.4% | at low | -96.2% | +117.4% | -78.5% | +174.5% |
| alltime | all time | -95.4% | +101.3% | -97.2% | +100.8% | -84.5% | +105.8% |
Galmed Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $614.00 K(-55.9%) | $4.72 M(+730.5%) |
| Jun 2024 | - | $1.39 M(+222.2%) | $568.00 K(-577.3%) |
| Mar 2024 | - | $432.00 K(-81.0%) | -$119.00 K(-114.9%) |
| Dec 2023 | $800.00 K(-95.4%) | $2.28 M(-164.5%) | $800.00 K(+60.0%) |
| Sep 2023 | - | -$3.54 M(-601.4%) | $500.00 K(-94.5%) |
| Jun 2023 | - | $705.00 K(-47.8%) | $9.16 M(-27.3%) |
| Mar 2023 | - | $1.35 M(-31.7%) | $12.61 M(-28.2%) |
| Dec 2022 | $17.56 M(+53.2%) | $1.98 M(-61.4%) | $17.56 M(-20.1%) |
| Sep 2022 | - | $5.13 M(+23.5%) | $21.97 M(+2.7%) |
| Jun 2022 | - | $4.15 M(-34.2%) | $21.40 M(+10.2%) |
| Mar 2022 | - | $6.31 M(-1.2%) | $19.41 M(+69.4%) |
| Dec 2021 | $11.46 M(-30.7%) | $6.38 M(+40.3%) | $11.46 M(+256.6%) |
| Sep 2021 | - | $4.55 M(+109.9%) | $3.21 M(-78.1%) |
| Jun 2021 | - | $2.17 M(-231.9%) | $14.66 M(+33.5%) |
| Mar 2021 | - | -$1.64 M(-11.8%) | $10.98 M(-33.6%) |
| Dec 2020 | $16.54 M(+147.6%) | -$1.86 M(-111.6%) | $16.54 M(-18.0%) |
| Sep 2020 | - | $15.99 M(-1160.0%) | $20.17 M(+3534.1%) |
| Jun 2020 | - | -$1.51 M(-138.6%) | $555.00 K(-108.8%) |
| Mar 2020 | - | $3.91 M(+121.1%) | -$6.33 M(-194.9%) |
| Dec 2019 | $6.68 M(-111.1%) | $1.77 M(-148.9%) | $6.68 M(+28.0%) |
| Sep 2019 | - | -$3.62 M(-56.9%) | $5.22 M(-82.9%) |
| Jun 2019 | - | -$8.40 M(-149.6%) | $30.51 M(-184.4%) |
| Mar 2019 | - | $16.93 M(+5342.4%) | -$36.15 M(-39.8%) |
| Dec 2018 | -$60.02 M | $311.00 K(-98.6%) | -$60.02 M(+25.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $21.68 M(-128.9%) | -$47.75 M(-40.8%) |
| Jun 2018 | - | -$75.06 M(+982.1%) | -$80.65 M(+2652.6%) |
| Mar 2018 | - | -$6.94 M(-155.2%) | -$2.93 M(-145.5%) |
| Dec 2017 | $6.44 M(+1.7%) | $12.58 M(-212.0%) | $6.44 M(-188.9%) |
| Sep 2017 | - | -$11.22 M(-522.7%) | -$7.25 M(-213.0%) |
| Jun 2017 | - | $2.65 M(+8.9%) | $6.41 M(-5.2%) |
| Mar 2017 | - | $2.44 M(-318.8%) | $6.76 M(+6.8%) |
| Dec 2016 | $6.34 M(-157.1%) | -$1.11 M(-145.7%) | $6.34 M(-32.4%) |
| Sep 2016 | - | $2.44 M(-19.0%) | $9.37 M(+47.9%) |
| Jun 2016 | - | $3.01 M(+49.8%) | $6.34 M(-36.9%) |
| Mar 2016 | - | $2.01 M(+4.5%) | $10.04 M(-190.4%) |
| Dec 2015 | -$11.11 M(+23.2%) | $1.92 M(-420.7%) | -$11.11 M(-49.6%) |
| Sep 2015 | - | -$599.00 K(-108.9%) | -$22.02 M(+2.8%) |
| Jun 2015 | - | $6.71 M(-135.1%) | -$21.43 M(-23.9%) |
| Mar 2015 | - | -$19.14 M(+112.8%) | -$28.15 M(+212.2%) |
| Dec 2014 | -$9.02 M(<-9900.0%) | -$9.00 M(>+9900.0%) | -$9.02 M(>+9900.0%) |
| Sep 2014 | - | -$5000.00(-37.5%) | -$20.00 K(-9.1%) |
| Jun 2014 | - | -$8000.00(+14.3%) | -$22.00 K(+46.7%) |
| Mar 2014 | - | -$7000.00(<-9900.0%) | -$15.00 K(-600.0%) |
| Dec 2013 | $3000.00(-109.4%) | $0.00(-100.0%) | $3000.00(0.0%) |
| Sep 2013 | - | -$7000.00(+600.0%) | $3000.00(-70.0%) |
| Jun 2013 | - | -$1000.00(-109.1%) | $10.00 K(-9.1%) |
| Mar 2013 | - | $11.00 K | $11.00 K |
| Dec 2012 | -$32.00 K | - | - |
FAQ
- What is Galmed Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual CFI year-on-year change?
- What is Galmed Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly CFI year-on-year change?
- What is Galmed Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals TTM CFI year-on-year change?
What is Galmed Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of GLMD is $800.00 K
What is the all time high annual CFI for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual cash flow from investing activities is $17.56 M
What is Galmed Pharmaceuticals annual CFI year-on-year change?
Over the past year, GLMD annual cash flow from investing activities has changed by -$16.76 M (-95.44%)
What is Galmed Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of GLMD is $614.00 K
What is the all time high quarterly CFI for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly cash flow from investing activities is $21.68 M
What is Galmed Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, GLMD quarterly cash flow from investing activities has changed by +$4.15 M (+117.37%)
What is Galmed Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of GLMD is $4.72 M
What is the all time high TTM CFI for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high TTM cash flow from investing activities is $30.51 M
What is Galmed Pharmaceuticals TTM CFI year-on-year change?
Over the past year, GLMD TTM cash flow from investing activities has changed by +$4.22 M (+843.40%)